Graham G. Walmsley

Average Profitability
<0.0001%
Insider Buys Quantity
16
Insider Buys Sum
$133.43M
Insider Sells Quantity
3
Insider Sells Sum
$26.91M

Insider Activity of Graham G. Walmsley

According to the SEC Form 4 filings, Graham G. Walmsley, being in a position of

  1. director at Olema Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 1401522 shares for $9.46M, and sold 2576522 shares for $26.91M,
    over all time since 2020-11-23, has bought 4361522 shares for $60.41M, and sold 2576522 shares for $26.91M.

The largest purchase of all time was on 2020-11-23 and amounted to 2320000 shares of Olema Pharmaceuticals, Inc. for $44.08M.

The largest sale of all time was on 2024-06-04 and amounted to 1175000 shares of Olema Pharmaceuticals, Inc. for $17.45M.

Biography of Graham G. Walmsley

No biography is available at this moment.

2024-12-17SaleOlema Pharmaceuticals, Inc.
OLMA
director
700,761
1.3522%
$6.75$4.73M-0.65%
2024-12-17PurchaseOlema Pharmaceuticals, Inc.
OLMA
director
700,761
1.3522%
$6.75$4.73M-0.65%
2024-12-13SaleOlema Pharmaceuticals, Inc.
OLMA
director
700,761
1.2508%
$6.75$4.73M-9.04%
2024-12-13PurchaseOlema Pharmaceuticals, Inc.
OLMA
director
700,761
1.2508%
$6.75$4.73M-9.04%
2024-06-04SaleOlema Pharmaceuticals, Inc.
OLMA
director
1.18M
2.2298%
$14.85$17.45M-15.13%
2023-12-08PurchaseAkero Therapeutics, Inc.
AKRO
director
100,000
0.179%
$19.83$1.98M+20.47%
2023-12-05PurchaseOlema Pharmaceuticals, Inc.
OLMA
director
131,870
0.2639%
$14.19$1.87M-8.85%
2023-12-01PurchaseAkero Therapeutics, Inc.
AKRO
director
50,000
0.0866%
$16.99$849,730+35.8%
2023-11-30PurchaseAkero Therapeutics, Inc.
AKRO
director
50,000
0.0904%
$16.90$844,835+42.37%
2023-09-19PurchaseAkero Therapeutics, Inc.
AKRO
director
400,000
0.5235%
$26.00$10.4M-56.54%
2023-09-12PurchaseOlema Pharmaceuticals, Inc.
OLMA
director
508,130
1.0101%
$9.84$5M+1.67%
2023-08-08PurchaseAkero Therapeutics, Inc.
AKRO
director
25,000
0.0442%
$42.06$1.05M-47.6%
2023-08-01PurchaseAkero Therapeutics, Inc.
AKRO
director
25,000
0.0453%
$43.26$1.08M-48.85%
2023-07-28PurchaseAkero Therapeutics, Inc.
AKRO
director
30,000
0.0645%
$42.69$1.28M-46.97%
2023-05-19PurchaseAkero Therapeutics, Inc.
AKRO
director
120,000
0.2354%
$42.00$5.04M-47.28%
2022-09-19PurchaseAkero Therapeutics, Inc.
AKRO
director
400,000
0.9981%
$26.00$10.4M+66.09%
2020-12-14PurchaseALX Oncology Holdings Inc.
ALXO
director
40,000
0.1009%
$76.00$3.04M-20.73%
2020-11-23PurchaseOlema Pharmaceuticals, Inc.
OLMA
director
2.32M
4.1436%
$19.00$44.08M-44.3%
2020-07-21PurchaseALX Oncology Holdings Inc.
ALXO
director
1.95M
4.0591%
$19.00$37.05M+90.48%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.